PuraPharm (HKSE:01498) Operating Cash Flow per Share : HK$0.26 (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is PuraPharm Operating Cash Flow per Share?

PuraPharm's operating cash flow per share for the six months ended in Dec. 2024 was HK$0.15. PuraPharm's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.26.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of PuraPharm was 30.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for PuraPharm's Operating Cash Flow per Share or its related term are showing as below:

During the past 11 years, PuraPharm's highest 3-Year average Operating Cash Flow per Share Growth Rate was -14.50% per year. The lowest was -23.60% per year. And the median was -19.05% per year.

HKSE:01498's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 8.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

PuraPharm Operating Cash Flow per Share Historical Data

The historical data trend for PuraPharm's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuraPharm Operating Cash Flow per Share Chart

PuraPharm Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.32

-0.04

0.22

0.20

0.26

PuraPharm Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.03	0.06	0.14	0.11	0.15

Competitive Comparison of PuraPharm's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, PuraPharm's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PuraPharm's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PuraPharm's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PuraPharm's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

PuraPharm Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

PuraPharm's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	103.985	/	395.053
	=	0.26

PuraPharm's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	60.86	/	395.053
	=	0.15

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.26

PuraPharm Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of PuraPharm's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PuraPharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PuraPharm Corporation Ltd (HKSE:01498) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

Wireless Centre, Phase One, Unit 201-207, 2nd Floor, Hong Kong Science Park, Tai Po, New Territories, Hong Kong, HKG

Website

https://www.purapharm.com

PuraPharm Corporation Ltd is a Hong Kong-based Chinese medicine Company. It is engaged in the research and development, production, marketing, and sale of concentrated Chinese medicine granules (CCMG) products marketed under the brand Nong's. The organization provides Chinese medical diagnostic services and operates through several segments: China CCMG, Hong Kong CCMG, Chinese healthcare products, Plantation, and Clinics. The majority of its revenue comes from the Hong Kong CCMG segment, which mainly involves the sale of CCMG products, excluding sales through self-operated clinics in Hong Kong. The group derives revenue from customers located in Hong Kong, Mainland China, and Other countries.

Executives

Chan Yu Ling, Abraham	2101 Beneficial owner
Man Yee Wai, Viola	2202 Interest of your spouse
Fullgold Development Limited	2101 Beneficial owner

PuraPharm Headlines

No Headlines